Tumor Antigen

Clinical Guidance

Immuno-Oncology

Overview

Cancer and the Immune System

Jennifer L. Ersek, PhD, MSPH; David M. Foureau, PhD; Edward S. Kim, MD, MBA, FACP, FASCO

Free clinical reference tool that includes treatment options; diagnosis information; guidelines; and more.

News

November 09, 2019

4 min read

Save

Autologous antigen-loaded vaccine safe, feasible for neuroblastoma

NATIONAL HARBOR, Md. — An investigational vaccine of autologous dendritic cells loaded with autologous tumor antigens was safe and feasible as an adjuvant therapy when given after standard care therapies for glioblastoma, according to phase 2 trial results presented at the Society for Immunotherapy of Cancer Annual Meeting.